Home › Familial Amyloid Neuropathies
Familial Amyloid Neuropathies clinical trials recruiting in the U.S.
17 studies for Familial Amyloid Neuropathies are recruiting participants at sites across the United States.
Cities with the most studies
- Boston, MA7 studies
- New York City, NY5 studies
- Dallas, TX4 studies
- Los Angeles, CA4 studies
- St. Louis, MO3 studies
- Cleveland, OH3 studies
- Rochester, MN3 studies
- Durham, NC3 studies
- Baltimore, MD3 studies
- San Diego, CA3 studies
- Philadelphia, PA3 studies
By state
- California5 studies
- Maryland3 studies
- Massachusetts7 studies
- Minnesota4 studies
- Missouri3 studies
- New York6 studies
- North Carolina4 studies
- Ohio4 studies
- Pennsylvania3 studies
- Texas5 studies
Recently updated studies
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT06465810Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
RecruitingObservational study
All ages · Women · Updated Sep 8, 2026 · NCT05040373ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
RecruitingObservational study
All ages · All sexes · Updated Sep 8, 2026 · NCT04561518Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
RecruitingObservational study
Ages 30 to 80 · All sexes · Updated Aug 31, 2026 · NCT05489549Ultrasound Therapy In Cardiac Amyloidosis
RecruitingPhase 4Healthy volunteers welcome
Ages 18 to 90 · All sexes · Updated Aug 21, 2026 · NCT04667494Cardiovascular Multimodality Imaging Study
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT06610019Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
RecruitingPhase 4
Ages 18 to 80 · All sexes · Updated Jul 29, 2026 · NCT07695701Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT05139797CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study
Recruiting
Ages 18 and older · All sexes · Updated Jul 21, 2026 · NCT06096675[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 21, 2026 · NCT07560306Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
RecruitingObservational studyHealthy volunteers welcome
Ages 50 and older · All sexes · Updated Jun 4, 2026 · NCT06034405Elevated Rate Pacing of Cardiac Amyloidosis
Recruiting
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT07583823A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT07308704Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study
RecruitingObservational study
Ages 30 to 80 · All sexes · Updated Jan 7, 2026 · NCT07196839US Benchmarking Clinical Study
RecruitingObservational studyHealthy volunteers welcome
Ages 60 and older · All sexes · Updated Oct 20, 2025 · NCT07215715Exercise Training in Transthyretin Cardiac Amyloidosis
Recruiting
Ages 60 to 90 · All sexes · Updated Mar 18, 2025 · NCT05797857From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.